Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.
InvestorsHub on MSN
Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M
Lunai Bioworks Inc. (NASDAQ:LNAI) said it has signed a binding agreement to purchase blood-brain barrier delivery technology ...
DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a strategic platform collaboration with Biostax Corp d/b/a Attune Biotech, SGP Holdings, and Callan JMB to lead U.S.-based ...
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
CD Bioparticles announces the launch of comprehensive Extrahepatic RNA Delivery services. NEW YORK, NY, UNITED STATES, ...
Microsponge-based drug delivery systems constitute an innovative approach in topical and systemic pharmaceutical formulations, designed to improve therapeutic efficacy while mitigating adverse effects ...
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...
Scientists at Xi'an Jiaotong-Liverpool University (XJTLU) and Nanjing University in China have developed a new drug delivery system that could improve how treatments of cancers and other diseases are ...
DDS can be based on physical mechanisms like osmosis, diffusion, erosion, dissolution, and electro-transport or biochemical methods like monoclonal antibodies, gene therapy, vector systems, ...
The modification of the liposomal surface by incorporating negatively charged lipids (e.g., by dicetylphosphate [DCP] incorporation), seems to increase the AM affinity to capture anionic liposomes via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results